MINOTTI, Linda
 Distribuzione geografica
Continente #
NA - Nord America 752
EU - Europa 313
AS - Asia 238
SA - Sud America 3
Totale 1.306
Nazione #
US - Stati Uniti d'America 743
CN - Cina 105
IT - Italia 87
DE - Germania 63
PL - Polonia 60
SG - Singapore 59
TR - Turchia 29
GB - Regno Unito 28
RU - Federazione Russa 21
ID - Indonesia 18
UA - Ucraina 16
SE - Svezia 14
VN - Vietnam 10
BE - Belgio 9
CA - Canada 9
FI - Finlandia 8
IN - India 6
IR - Iran 4
BR - Brasile 3
PK - Pakistan 3
LT - Lituania 2
NL - Olanda 2
RO - Romania 2
AZ - Azerbaigian 1
ES - Italia 1
JP - Giappone 1
KG - Kirghizistan 1
TW - Taiwan 1
Totale 1.306
Città #
Fairfield 97
Chandler 77
Warsaw 60
Woodbridge 57
Singapore 48
Santa Clara 47
Ashburn 43
Wilmington 37
Ferrara 36
Cambridge 32
Houston 31
New York 29
Seattle 29
Munich 24
Ann Arbor 23
Beijing 18
Jakarta 18
Shanghai 17
Jacksonville 15
Princeton 15
Addison 14
Bremen 14
Izmir 13
Nanjing 12
Dong Ket 10
Brussels 9
Helsinki 8
London 8
Milan 8
Changsha 6
Los Angeles 6
Shenyang 6
Toronto 6
San Diego 5
Cagliari 4
Frankfurt am Main 4
Guangzhou 4
Hebei 4
Leawood 4
Redwood City 4
Andover 3
Augusta 3
Boardman 3
Dartford 3
Faenza 3
Ithaca 3
Jinan 3
Lahore 3
Nanchang 3
Pasadena 3
San Mateo 3
Savignano sul Rubicone 3
Wuhan 3
Baltimore 2
Dearborn 2
Florence 2
Hounslow 2
Isfahan 2
Istanbul 2
Jiaxing 2
Kunming 2
Massa Fiscaglia 2
Mumbai 2
Ningbo 2
Ottawa 2
Piscataway 2
Rugeley 2
San Martino di Lupari 2
São Paulo 2
Tianjin 2
Aosta 1
Ardabil 1
Bainbridge Island 1
Baku 1
Baoding 1
Bishkek 1
Brighton 1
Caserta 1
Chicago 1
Clifton 1
Columbus 1
Falkenstein 1
Falls Church 1
Ferrara di Monte Baldo 1
Florianópolis 1
Grosseto 1
Gualtieri 1
Haikou 1
Hangzhou 1
Harrogate 1
Huskvarna 1
Kartal 1
Marano 1
Montreal 1
Mountain View 1
Orange 1
Piemonte 1
San Lazzaro di Savena 1
Stanford 1
Stienta 1
Totale 1.005
Nome #
Loss of miR-204 expression is a key event in melanoma 174
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 142
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset 134
Analysis of Differential Expression of TG2 Variants During Treatment with Retinoic Acid Highlights a New 3'-Terminal Transcript and Putatively Involved Proteins 109
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants 104
RNA analysis indicates tight correlation between the expression of a long non coding RNA and the TG2 mRNA levels 98
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts 88
Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study 84
The network of non-coding RNAs in cancer drug resistance 79
SNPs and somatic mutation on long non-coding RNA: New frontier in the cancer studies? 78
Regulatory RNAs of the Transglutaminase 2 gene interfere with its expression in leukaemic cell lines after ATRA treatment 70
ATRA modulates the expression of alternative Transglutaminase 2 in brain tumors through interactions between regulatory factors and intronic regions 68
Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer 63
Novel RNAs in cancer: large scale analysis of Affymetrix Human Exon chips and Next Generation Sequencing 59
Totale 1.350
Categoria #
all - tutte 7.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.432


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202097 0 0 0 0 0 13 10 8 16 34 2 14
2020/2021295 9 22 23 16 45 29 13 30 12 40 42 14
2021/2022168 10 14 20 4 13 5 11 4 7 7 19 54
2022/2023166 16 15 12 12 34 16 8 17 23 2 10 1
2023/2024125 8 7 6 7 7 34 6 10 3 9 5 23
2024/2025253 12 41 41 43 60 56 0 0 0 0 0 0
Totale 1.350